GOING NORTH TODAY {CDFT:QB} .DEBT FREE CC MERCHANT ACC.

New Post Public Reply Private Reply Replies (0) Message Board
WARMBUFFETT

GOING NORTH TODAY {CDFT:QB} . DEBT FREE CC MERCHANT ACC. SERVICES COMPANY EXPANDS TO B.D.C. CDFT's Management believes that being a BDC entity is best suited for Company and its shareholders. A requirement to become a BDC, the Company needs to maintains a Net Asset Value and debt obligation below equity. At this time, the Company meets these current financial conditions and will move forward with a 1934 Act Registration Statement.

Dennis Radcliffe, Director, states, "One of my corporate goals moving forward will be to spearhead the due diligence review of new opportunities that this public company would be looking to purchase. The key now is to buy assets that have an income component attached, that we can identify and verify so as to enhance Citadel's retained earnings."

Gary DeRoos, CEO, states, "The addition of Dennis Radcliffe to the Board of Directors is part of Citadel EFT's overall objective to pursue an uplifting onto the American Stock Exchange-AMEX . To date we are debt free, don't have a going concern, and now have purchased assets that the Company can book as equity on its balance sheet. Adding a new Board member makes sense in light of the size of the transaction, and it further helps the Company to meet its obligation to expand its business interests beyond its current operations."
Citadel EFT, Inc. (OTCQB: CDFT) CEO Gary DeRoos announced today that the company has purchased in excess of $10 Million in appraised, audited and unencumbered assets with the goal of making application and being listed on the American Stock Exchange (AMEX).

Follow me to the TRII board, 20 bagger by XMAS
BRAND NEW MILL READY TO CHEW!
Cash-Flow Positive in less than Two Q's

53225022_trio-logo-header-small.jpg
1945865170_xxl[oTRIO_Logo_.jpg

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Kenox Pharmaceuticals Revolutionizes Drug Development Landscape

Updated Category News Views 272

Revolutionizing Drug Development Approaches Kenox Pharmaceuticals Inc, a leading name in the development of innovative Orally Inhaled and Nasal Drug Products (OINDPs), has recently announced an exciting extension of its capabilities. The introduction of small scale non-sterile GMP capabilities marks a significant enhancement to its already comprehensive drug development...

Continue Reading
Exciting Listing of AI-themed ATC Coin on CoinW Exchange

Updated Category News Views 211

Exciting Listing of AI-themed ATC Coin on CoinW Exchange CoinW, recognized as a trailblazer in the realm of cryptocurrency trading platforms, is thrilled to announce the listing of ATC, an innovative meme coin designed around artificial intelligence. ATC will be available for trading in both AI, MEME, and SOL Zones. To celebrate this momentous occasion, which marks an...

Continue Reading
Webstar Technology Group’s Innovative Blockchain Venture

Updated Category News Views 370

Revolutionizing Real Estate with Blockchain Tokenization Webstar Technology Group (OTCMKTS: WBSR) is stepping into the future with a bold initiative that harnesses the power of blockchain technology for real estate ventures. This forward-thinking approach not only highlights the company's commitment to innovation but also positions it as a leader in the rapidly evolving...

Continue Reading
Class Action Lawsuits Update: ATYR, MLTX, BAX, JHX

Updated Category News Views 167

Overview of Recent Class Action Lawsuits Several publicly traded companies are facing legal challenges with class action lawsuits initiated on behalf of their shareholders. It's crucial for investors in these companies to be aware of their rights and the deadlines for potential legal actions. This article discusses the companies involved and provides essential information...

Continue Reading
Biodesix Strengthens Partnership with Bio-Rad for Advanced Testing

Updated Category News Views 164

Partnership Expansion Between Biodesix and Bio-Rad Biodesix, Inc. (NYSE: BDSX), a prominent diagnostics solutions company, has recently strengthened its collaboration with Bio-Rad Laboratories. This expanded partnership focuses on developing and validating advanced in vitro diagnostic assays aimed at enhancing the detection of genomic markers in oncology applications....

Continue Reading